A history of the term "DMARD"

被引:25
作者
Buer, Jonas Kure [1 ]
机构
[1] Univ Oslo, Dept Social Anthropol, N-0317 Oslo, Norway
关键词
DMARD; SAARD; RID; DC-ART; Drug classes; Rheumatology; History; Anthropology; ACTING ANTIRHEUMATIC DRUGS; REMISSION-INDUCING DRUGS; DISEASE-MODIFYING DRUGS; RHEUMATOID-ARTHRITIS; CLASSIFICATION; THERAPY; SAARDS; AZATHIOPRINE; COMBINATION;
D O I
10.1007/s10787-015-0232-5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The article outlines a history of the concept of "disease-modifying antirheumatic drugs" or DMARDs-from the emergence in the 1970s of the idea of drugs with decisive long-term effects on bone erosion in rheumatoid arthritis (RA), through the consolidation and popularisation in the term DMARD in 1980s and 1990s. It then examines the usage of the terms "remission-inducing drugs" (RIDs) and "slow-acting anti-rheumatic drugs" (SAARDs), which for some years offered competition to the term DMARDs, thus underscoring the contingency of the establishment of DMARD as a word. Finally, it juxtaposes the apparently spontaneous emergence of the three terms DMARD, SAARD and RID, and the disappearance of the latter two, with a failed attempt in the early 1990s to replace these terms with the new term "disease-controlling antirheumatic treatment" (DC-ART). The analysis highlights the paradoxical qualities of the DMARD concept as robust albeit tension ridden, while playing down the role of identified individuals and overarching explanations of purpose.
引用
收藏
页码:163 / 171
页数:9
相关论文
共 50 条
  • [41] Disease-modifying Antirheumatic Drugs (DMARD) and Combination Therapy of Conventional DMARD in Patients with Spondyloarthritis and Psoriatic Arthritis with Axial Involvement
    Simone, Davide
    Nowik, Marcin
    Gremese, Elisa
    Ferraccioli, Gianfranco F.
    JOURNAL OF RHEUMATOLOGY, 2015, 42 : 65 - 69
  • [42] Pharmacotherapeutic strategies for disease-modifying antirheumatic drug (DMARD) combinations to treat rheumatoid arthritis (RA)
    Münster, T
    Furst, DE
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1999, 17 (06) : S29 - S36
  • [43] Conventional DMARD options for patients with a suboptimal response to methotrexate
    O'Dell, J
    JOURNAL OF RHEUMATOLOGY, 2001, 28 : 21 - 26
  • [44] Rheumatology nurse specialists and DMARD education - Is it fit for purpose?
    Begum, Julie
    Nisar, Muhammad K.
    INTERNATIONAL JOURNAL OF NURSING STUDIES, 2017, 69 : 98 - 99
  • [45] Early DAS response after DMARD-start increases probability of achieving sustained DMARD-free remission in rheumatoid arthritis
    M. Verstappen
    E. Niemantsverdriet
    X. M. E. Matthijssen
    S. le Cessie
    A. H. M. van der Helm-van Mil
    Arthritis Research & Therapy, 22
  • [46] Improved health outcomes with Etanercept versus usual DMARD therapy in an Asian population with established rheumatoid arthritis
    Bae, Sang-Cheol
    Gun, Suk Chyn
    Mok, Chi Chiu
    Khandker, Rezaul
    Nab, Henk W.
    Koenig, Andrew S.
    Vlahos, Bonnie
    Pedersen, Ron
    Singh, Amitabh
    BMC MUSCULOSKELETAL DISORDERS, 2013, 14
  • [47] IgA anti-citrullinated protein antibodies are associated with flares during DMARD tapering in rheumatoid arthritis
    Sokolova, Maria, V
    Hagen, Melanie
    Bang, Holger
    Schett, Georg
    Rech, Juergen
    Steffen, Ulrike
    RHEUMATOLOGY, 2022, 61 (05) : 2124 - 2131
  • [48] Torcular Herophili: A Review of the History of the Term and Synonyms
    McCormack, Isabella G.
    Neumann, Paul E.
    Tubbs, R. Shane
    WORLD NEUROSURGERY, 2022, 159 : 120 - 125
  • [49] Assessments of the unmet need in the management of patients with rheumatoid arthritis: analyses from the NOR-DMARD registry
    Olsen, Inge C.
    Lie, Elisabeth
    Vasilescu, Radu
    Wallenstein, Gene
    Strengholt, Sander
    Kvien, Tore K.
    RHEUMATOLOGY, 2019, 58 (03) : 481 - 491
  • [50] Triple DMARD combination for rheumatoid arthritis resistant to methotrexate and steroid combination: a single-center experience
    Isik, Metin
    Halacli, Burcin
    Atmaca, Ozgur
    Etgul, Sezgin
    Dogan, Ismail
    Kilinc, Levent
    Calguneri, Meral
    RHEUMATOLOGY INTERNATIONAL, 2013, 33 (06) : 1425 - 1427